You are here
Aspiration & Biopsy Needles: Worldwide Market Analysis (2019-2024) by Product, Site, Procedure, and End-user
DUBLIN, July 11, 2019 /PRNewswire/ --
The "Aspiration & Biopsy Needles Market by Product (Fine-needle Aspiration, Biopsy (Core & Vacuum Assisted)), Site, Procedure (Image-guided (Ultrasound, MRI, Stereotactic), Nonimage-guided), Enduser (Hospital, Academia) - Global Forecast to 2024" report has been added to ResearchAndMarkets.com's offering.
The global aspiration and biopsy needles market is valued at USD 893.6 million in 2019 and expected to reach USD 1,272 million by 2024, at a CAGR of 7.3% from 2019 to 2024.
The adoption of aspiration and biopsy needles is growing across major healthcare markets owing to the increasing incidence of cancer and the rising patient preference for minimally invasive diagnostic procedures. The Biopsy Needles segment is expected to witness the highest growth in the aspiration and biopsy needles market during the forecast period.
On the basis of product, the aspiration and biopsy needles market is segmented into biopsy and aspiration needles. The biopsy needles segment is estimated to grow at the highest CAGR during the forecast period owing to its growing adoption among various healthcare facilities and due to the rising prevalence of cancer. The Hospitals segment is expected to witness the highest growth during the forecast period.
On the basis of the end user, the aspiration and biopsy needles market is segmented into hospitals, research laboratories, academic institutes, and diagnostic and imaging centers. The hospital's segment is estimated to grow at the highest rate during the forecast period due to the rising prevalence of cancer, increasing preference for minimally invasive procedures in hospital settings, and developing healthcare infrastructure in emerging countries.
On the basis of site, the breast segment is expected to hold the largest share of the market in 2019. On the basis of site, the aspiration and biopsy needles market is segmented into breast, lung, colorectal, prostate, kidney, and bone marrow.
The breast segment accounted for the largest share of the aspiration and biopsy needles market in 2019. The large share of this segment is mainly attributed to the rising prevalence of breast cancer as well as growing awareness about the disease and increasing research activity pertaining to breast screening and diagnosis Image-guided procedure segment is expected to witness the highest growth during the forecast period.
On the basis of procedure, the aspiration and biopsy needles market is segmented into image-guided procedures and non image-guided procedures. The image-guided procedure segment is projected to grow at the highest CAGR during the forecast period due to the rising preference for minimally invasive biopsy and aspiration procedures.
Key Topics Covered
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency Used for the Study
1.5 Market Stakeholders
2 Research Methodology
2.1 Research Approach
2.1.1 Secondary Sources
22.214.171.124 Key Data From Secondary Sources
2.1.2 Primary Sources
126.96.36.199 Key Data From Primary Sources
2.2 Market Size Estimation
2.2.1 Product-Based Market Estimation
2.2.2 End User-Based Market Estimation
2.2.3 Primary Research Validation
2.3 Market Breakdown and Data Triangulation
2.4 Market Share Estimation
2.5 Assumptions for the Study
3 Executive Summary
4 Premium Insights
4.1 Aspiration and Biopsy Needles Market Overview
4.2 Aspiration and Biopsy Needles Market Share, By Product
4.3 Aspiration and Biopsy Needles Market, By End User, 2019 Vs. 2024 (USD Million)
4.4 Aspiration and Biopsy Needles Market, By Procedure, 2019 Vs. 2024 (USD Million)
4.5 Aspiration and Biopsy Needles Market, By Site, 2019 Vs. 2024 (USD Million)
4.6 Aspiration and Biopsy Needles Market, By Region
5 Market Overview
5.1 Market Dynamics
188.8.131.52 Rising Prevalence of Cancer
184.108.40.206 Cancer Awareness Initiatives Undertaken By Governments and Global Health Organizations
220.127.116.11 Increasing Preference for Minimally Invasive Biopsies
18.104.22.168 Risk of Infections Associated With the use of Aspiration and Biopsy Needles
22.214.171.124 Emerging Economies
126.96.36.199 Underdeveloped Healthcare Infrastructure and Dearth of Well-Trained Radiologists and Oncologists
5.2 Industry Trends
5.2.1 Emergence of Liquid Biopsy
6 Aspiration and Biopsy Needles Market, By Product
6.2 Biopsy Needles
6.2.1 Biopsy Needles Market Split, By Site, 2017-2024 (USD Million)
6.2.2 Biopsy Needles Market Split, By Procedure, 2017-2024 (USD Million)
6.2.3 Biopsy Needles Market Split, By End User, 2017-2024 (USD Million)
6.2.4 CNB Needles
188.8.131.52 Low Procedural Costs, Accuracy, and Rapidity of Core Needle Biopsy Procedures Will Drive Demand for Associated Needles
6.2.8 VAB Needles
184.108.40.206 High Diagnostic Specificity of Vacuum-Assisted Biopsy is Likely to Drive Market Growth
6.3 Aspiration Needles
6.3.1 Low Accuracy and the Possibility of False-Positive Results Have Hindered the Adoption of Aspiration Needles
7 Aspiration and Biopsy Needles Market, By Procedure
7.2 Image-Guided Procedures
7.2.4 Other Image-Guided Procedures
7.3 Nonimage-Guided Procedures
8 Aspiration and Biopsy Needles Market, By Site
8.7 Bone and Bone Marrow
8.8 Other Sites
9 Aspiration and Biopsy Needles Market, By Region
9.2 North America
9.5 Rest of World (RoW)
10 Competitive Landscape
10.2 Market Ranking Analysis
10.3 Competitive Scenario
10.3.1 Product Launches and Approvals
10.4 Competitive Leadership Mapping
10.4.1 Competitive Leadership Mapping: Major Market Players (2017)
10.4.1.1 Visionary Leaders
10.4.1.3 Dynamic Players
10.4.1.4 Emerging Companies
11 Company Profiles
11.1 Argon Medical Devices, Inc.
11.2 Becton, Dickinson and Company (BD)
11.3 Boston Scientific Corporation
11.4 Cardinal Health, Inc.
11.5 CONMED Corporation
11.6 Cook Group Incorporated
11.7 HAKKO CO.,LTD Medical Device Division
11.8 INRAD Inc.
11.9 Medtronic, Plc
11.10 Merit Medical Systems
11.11 Olympus Corporation
11.12 Ranfac Corporation
11.13 Remington Medical Inc.
11.14 Somatex Medical Technologies
11.15 Stryker Corporation
For more information about this report visit https://www.researchandmarkets.com/r/fky6ro
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
Research and Markets
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets